HR. 5197In Committee
Protect Beneficiaries from Middlemen Act
Limits Medicare Part D and Medicare Advantage drug cost sharing above the deductible to the lower of a drug's average net price or cash price
Plain-English overview
What this bill does
Limits Medicare Part D and Medicare Advantage drug cost sharing above the deductible to the lower of a drug's average net price or cash price
Key points
- Require GAO implementation report
- Limit drug cost sharing
Current status
Where it stands
Status
In Committee
Latest action
2025-09-08 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Related context
Topics and policy areas
undefinedHealth